These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 28400526)

  • 21. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemisinin resistance phenotypes and K13 inheritance in a
    Sá JM; Kaslow SR; Krause MA; Melendez-Muniz VA; Salzman RE; Kite WA; Zhang M; Moraes Barros RR; Mu J; Han PK; Mershon JP; Figan CE; Caleon RL; Rahman RS; Gibson TJ; Amaratunga C; Nishiguchi EP; Breglio KF; Engels TM; Velmurugan S; Ricklefs S; Straimer J; Gnädig NF; Deng B; Liu A; Diouf A; Miura K; Tullo GS; Eastman RT; Chakravarty S; James ER; Udenze K; Li S; Sturdevant DE; Gwadz RW; Porcella SF; Long CA; Fidock DA; Thomas ML; Fay MP; Sim BKL; Hoffman SL; Adams JH; Fairhurst RM; Su XZ; Wellems TE
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12513-12518. PubMed ID: 30455312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
    Mukherjee A; Bopp S; Magistrado P; Wong W; Daniels R; Demas A; Schaffner S; Amaratunga C; Lim P; Dhorda M; Miotto O; Woodrow C; Ashley EA; Dondorp AM; White NJ; Wirth D; Fairhurst R; Volkman SK
    Malar J; 2017 May; 16(1):195. PubMed ID: 28494763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updates on k13 mutant alleles for artemisinin resistance in Plasmodium falciparum.
    Zaw MT; Emran NA; Lin Z
    J Microbiol Immunol Infect; 2018 Apr; 51(2):159-165. PubMed ID: 28711439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of different mutations on Kelch13 protein levels, ART resistance, and fitness cost in
    Behrens HM; Schmidt S; Henshall IG; López-Barona P; Peigney D; Sabitzki R; May J; Maïga-Ascofaré O; Spielmann T
    mBio; 2024 Jun; 15(6):e0198123. PubMed ID: 38700363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.
    Ariey F; Witkowski B; Amaratunga C; Beghain J; Langlois AC; Khim N; Kim S; Duru V; Bouchier C; Ma L; Lim P; Leang R; Duong S; Sreng S; Suon S; Chuor CM; Bout DM; Ménard S; Rogers WO; Genton B; Fandeur T; Miotto O; Ringwald P; Le Bras J; Berry A; Barale JC; Fairhurst RM; Benoit-Vical F; Mercereau-Puijalon O; Ménard D
    Nature; 2014 Jan; 505(7481):50-5. PubMed ID: 24352242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13.
    Gnädig NF; Stokes BH; Edwards RL; Kalantarov GF; Heimsch KC; Kuderjavy M; Crane A; Lee MCS; Straimer J; Becker K; Trakht IN; Odom John AR; Mok S; Fidock DA
    PLoS Pathog; 2020 Apr; 16(4):e1008482. PubMed ID: 32310999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of K13 mutation and Day-3 positive parasitaemia in artemisinin-resistant malaria endemic area of Cambodia: a cross-sectional study.
    Kheang ST; Sovannaroth S; Ek S; Chy S; Chhun P; Mao S; Nguon S; Lek DS; Menard D; Kak N
    Malar J; 2017 Sep; 16(1):372. PubMed ID: 28903755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
    Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
    Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoperoxide-based compounds: cross-resistance with artemisinins and selection of a Plasmodium falciparum lineage with a K13 non-synonymous polymorphism.
    Paloque L; Witkowski B; Lelièvre J; Ouji M; Ben Haddou T; Ariey F; Robert A; Augereau JM; Ménard D; Meunier B; Benoit-Vical F
    J Antimicrob Chemother; 2018 Feb; 73(2):395-403. PubMed ID: 29177421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors.
    Ocan M; Akena D; Nsobya S; Kamya MR; Senono R; Kinengyere AA; Obuku E
    Malar J; 2019 Mar; 18(1):60. PubMed ID: 30846002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
    Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
    Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations.
    Zhang J; Li N; Siddiqui FA; Xu S; Geng J; Zhang J; He X; Zhao L; Pi L; Zhang Y; Li C; Chen X; Wu Y; Miao J; Cao Y; Cui L; Yang Z
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():20-27. PubMed ID: 31009824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular insights into artemisinin resistance in Plasmodium falciparum: An updated review.
    Azmi WA; Rizki AFM; Djuardi Y; Artika IM; Siregar JE
    Infect Genet Evol; 2023 Aug; 112():105460. PubMed ID: 37269964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Proteasome Mutation Sensitizes
    Rosenthal MR; Ng CL
    ACS Infect Dis; 2021 Jul; 7(7):1923-1931. PubMed ID: 33971094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding artemisinin-resistant malaria: what a difference a year makes.
    Fairhurst RM
    Curr Opin Infect Dis; 2015 Oct; 28(5):417-25. PubMed ID: 26237549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of kelch 13 C580Y mutation in the studies of artemisinin resistance in Plasmodium falciparum in Greater Mekong Subregion.
    Zaw MT; Lin Z; Emran NA
    J Microbiol Immunol Infect; 2020 Oct; 53(5):676-681. PubMed ID: 31563454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016.
    Thuy-Nhien N; Tuyen NK; Tong NT; Vy NT; Thanh NV; Van HT; Huong-Thu P; Quang HH; Boni MF; Dolecek C; Farrar J; Thwaites GE; Miotto O; White NJ; Hien TT
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.